1. PROTAC Immunology/Inflammation Metabolic Enzyme/Protease Cell Cycle/DNA Damage
  2. Hsp-targeting Chimeras LYTACs PD-1/PD-L1 HSP
  3. Hsp70TAC PD-1 Degrader-2

Hsp70TAC PD-1 Degrader-2 is a PD-L1 Hsp70TAC (Hsp70-targeting Chimeras) degrader with Kd values of 0.36 μM. Hsp70TAC PD-1 Degrader-2 forms a ternary complex with Hsp70 and PD-L1 to drive PD-L1 degradation. Hsp70TAC PD-1 Degrader-2 induces degradation of mature membrane-bound PD-L1 in an Hsp70-dependent manner and via caveolin-mediated endocytosis and lysosomal trafficking. Hsp70TAC PD-1 Degrader-2 accumulates preferentially in tumor cells with elevated Hsp70 expression for tumor-selective PD-L1 degradation. Hsp70TAC PD-1 Degrader-2 can be used for the research of cancer, such as breast invasive carcinoma, glioblastoma multiforme, diffuse large b-cell lymphoma. (Pink: PD-1/PD-L1 ligand (HY-19745A); Blue: Hsp70 ligand (HY-182979); Black: linker (HY-182982)).

For research use only. We do not sell to patients.

Hsp70TAC PD-1 Degrader-2

Hsp70TAC PD-1 Degrader-2 Chemical Structure

Size Stock
50 mg   Get quote  
100 mg   Get quote  
250 mg   Get quote  

* Please select Quantity before adding items.

This product is a controlled substance and not for sale in your territory.

Top Publications Citing Use of Products

View All Hsp-targeting Chimeras Isoform Specific Products:

View All HSP Isoform Specific Products:

  • Biological Activity

  • Purity & Documentation

  • References

  • Customer Review

Description

Hsp70TAC PD-1 Degrader-2 is a PD-L1 Hsp70TAC (Hsp70-targeting Chimeras) degrader with Kd values of 0.36 μM. Hsp70TAC PD-1 Degrader-2 forms a ternary complex with Hsp70 and PD-L1 to drive PD-L1 degradation. Hsp70TAC PD-1 Degrader-2 induces degradation of mature membrane-bound PD-L1 in an Hsp70-dependent manner and via caveolin-mediated endocytosis and lysosomal trafficking. Hsp70TAC PD-1 Degrader-2 accumulates preferentially in tumor cells with elevated Hsp70 expression for tumor-selective PD-L1 degradation. Hsp70TAC PD-1 Degrader-2 can be used for the research of cancer, such as breast invasive carcinoma, glioblastoma multiforme, diffuse large b-cell lymphoma[1]. (Pink: PD-1/PD-L1 ligand (HY-19745A); Blue: Hsp70 ligand (HY-182979); Black: linker (HY-182982)).

IC50 & Target[1]

HSP70

4.18 μM (Kd)

In Vitro

Hsp70TAC PD-1 Degrader-2 (Compound SP-2) (6.25-100 μM) binds to purified Hsp70 with a KD of 4.18 μM and to purified PD-L1 with a KD of 0.36 μM[1].
Hsp70TAC PD-1 Degrader-2 (0.1-10 μM; 4-24 h) induces time- and dose-dependent degradation of PD-L1 in MDA-MB-231 cells (DC50 = 0.84 μM) and U-87 MG cells (DC50 = 1.23 μM)[1].
Hsp70TAC PD-1 Degrader-2 (1-5 μM; 24 h) effectively degrades mature membrane-bound PD-L1 in MDA-MB-231 cells[1].
Hsp70TAC PD-1 Degrader-2 (1 μM; 2-12 h) induces PD-L1 degradation in MDA-MB-231 cells via a lysosome-dependent pathway, which requires formation of a PD-L1-SP-2-Hsp70 ternary complex[1].
Hsp70TAC PD-1 Degrader-2 (1 μM; 12 h)-mediated PD-L1 degradation in MDA-MB-231 cells is dependent on Hsp70 expression and caveolin-mediated endocytosis[1].
Hsp70TAC PD-1 Degrader-2 (1-5 μM; 12 h) selectively induces PD-L1 degradation in Hsp70-overexpressing tumor cells (MDA-MB-231, U-87 MG, MCF-7, U937), but not in low Hsp70-expressing normal cells (HEK293T, MEF) or TE-1 cells[1].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Western Blot Analysis[1]

Cell Line: MDA-MB-231 (triple-negative breast cancer), U-87 MG (glioblastoma multiforme)
Concentration: 0.1, 0.5, 1, 5, 10 μM
Incubation Time: 4, 8, 12, 24 h
Result: Induced time-dependent PD-L1 degradation starting at 8 h, with >80% depletion achieved at 24 h in both cell lines.
Yielded dose-dependent degradation with DC50 values of 0.84 μM in MDA-MB-231 cells and 1.23 μM in U-87 MG cells, with no observed "hook effect" at high concentrations.

Immunofluorescence[1]

Cell Line: MDA-MB-231
Concentration: 1, 5 μM
Incubation Time: 24 h
Result: Reduced cell surface PD-L1 fluorescence signal as shown by immunofluorescence.
Confirmed a significant reduction in PD-L1-positive cells after treatment with 1 μM SP-2 for 24 h, compared to the DMSO control via flow cytometry.
Molecular Weight

950.24

Formula

C56H67N7O5S

SMILES

COC1=NC(OCC2=C(C(C3=CC=CC=C3)=CC=C2)C)=CC=C1CNCCNC(CCCCCCC(NCCN(CCNC4=C(C(C5=C6C(C(SC7CCCCC7)=CC=C46)=CC=C5)=O)C#N)C)=O)=O

Shipping

Room temperature in continental US; may vary elsewhere.

Storage

Please store the product under the recommended conditions in the Certificate of Analysis.

Purity & Documentation
References
  • No file chosen (Maximum size is: 1024 Kb)
  • If you have published this work, please enter the PubMed ID.
  • Your name will appear on the site.
  • Molarity Calculator

  • Dilution Calculator

The molarity calculator equation

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass   Concentration   Volume   Molecular Weight *
= × ×

The dilution calculator equation

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)

This equation is commonly abbreviated as: C1V1 = C2V2

Concentration (start) × Volume (start) = Concentration (final) × Volume (final)
× = ×
C1   V1   C2   V2
Help & FAQs
  • Do most proteins show cross-species activity?

    Species cross-reactivity must be investigated individually for each product. Many human cytokines will produce a nice response in mouse cell lines, and many mouse proteins will show activity on human cells. Other proteins may have a lower specific activity when used in the opposite species.

Your Recently Viewed Products:

Inquiry Online

Your information is safe with us. * Required Fields.

Product Name

 

Requested Quantity *

Applicant Name *

 

Salutation

Email Address *

 

Phone Number *

Department

 

Organization Name *

City

State

Country or Region *

     

Remarks

Bulk Inquiry

Inquiry Information

Product Name:
Hsp70TAC PD-1 Degrader-2
Cat. No.:
HY-182959
Quantity:
MCE Japan Authorized Agent: